Investigation of morpholine isosters for the development of a potent, selective and metabolically stable mTOR kinase inhibitor
- DOI
- 10.1016/j.ejmech.2022.115038
- Published
- 2023-02
- Container
- European Journal of Medicinal Chemistry
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.ejmech.2022.115038,
title = {Investigation of morpholine isosters for the development of a potent, selective and metabolically stable mTOR kinase inhibitor},
author = {Martina De Pascale and Lukas Bissegger and Chiara Tarantelli and Florent Beaufils and Alessandro Prescimone and Hayget Mohamed Seid Hedad and Omar Kayali and Clara Orbegozo and Luka Raguž and Thorsten Schaefer and Paul Hebeisen and Francesco Bertoni and Matthias P. Wymann and Chiara Borsari},
year = {2023},
journal = {European Journal of Medicinal Chemistry},
doi = {10.1016/j.ejmech.2022.115038},
url = {https://doi.org/10.1016/j.ejmech.2022.115038}
}RIS
TY - JOUR TI - Investigation of morpholine isosters for the development of a potent, selective and metabolically stable mTOR kinase inhibitor AU - Martina De Pascale AU - Lukas Bissegger AU - Chiara Tarantelli AU - Florent Beaufils AU - Alessandro Prescimone AU - Hayget Mohamed Seid Hedad AU - Omar Kayali AU - Clara Orbegozo AU - Luka Raguž AU - Thorsten Schaefer AU - Paul Hebeisen AU - Francesco Bertoni AU - Matthias P. Wymann AU - Chiara Borsari PY - 2023 JO - European Journal of Medicinal Chemistry DO - 10.1016/j.ejmech.2022.115038 UR - https://doi.org/10.1016/j.ejmech.2022.115038 ER -
APA
Pascale, M. D., Bissegger, L., Tarantelli, C., Beaufils, F., Prescimone, A., Hedad, H. M. S., Kayali, O., Orbegozo, C., Raguž, L., Schaefer, T., Hebeisen, P., Bertoni, F., Wymann, M. P., & Borsari, C. (2023). Investigation of morpholine isosters for the development of a potent, selective and metabolically stable mTOR kinase inhibitor. European Journal of Medicinal Chemistry. https://doi.org/10.1016/j.ejmech.2022.115038
Source records
- crossref · retrieved 2026-09-26T01:49:36.479Z